A Novel Cooling Device for Pain Management During Fingerstick Blood Draw

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05329493
Collaborator
(none)
12
1
1
7
1.7

Study Details

Study Description

Brief Summary

In this study, the investigators seek to evaluate a novel tissue-cooling device for pain management during needle sticks and /or blood draw on the fingertips.

Condition or Disease Intervention/Treatment Phase
  • Device: Cooling digit device application
N/A

Detailed Description

Patient compliance with laboratory testing is one of the most underrecognized challenges in developing a treatment plan for acute and chronically ill patients. The ability to offer alternatives to standard venipuncture blood draws would greatly increase a laboratory's ability to provide testing to patients and health care providers.The fingerstick blood draw has been used as an alternative.

Aiming a less painful, potentially easier alternative we devised a novel that can be applied distally on the digit prior to the blood collection procedure and may provide analgesia through a liquid coolant that is run through tubes in the device to safely cool tissue to achieve numbing. We hypothesize that this device will safely and effectively reduce the pain associated with the fingertip pricks and increase the amount of capillary blood collected.

Multiple punctures with a large lancet were a frequent cause of discomfort among patients.With this new device the discomfort will be reduced by its application followed by the numbness of the finger.

The investigators plan to have 12 patients to complete the study. Subjects must be equal to greater than 18 years old and younger than 60 years older and may be any gender or Fitzpatrick skin type.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Novel Cooling Device for Pain Management During Fingerstick Blood Draw
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cooling digit device application

Device: Cooling digit device. The cooling finger device will be applied in the subjects on their right hand. Subjects will serve as their own control.

Device: Cooling digit device application
Cooling digit device will be applied on subject's right hand ( fifth finger).
Other Names:
  • cooling finger device
  • Outcome Measures

    Primary Outcome Measures

    1. Wong-Baker FACES Pain Rating Scale [day 1]

      This scale will be used to record subject pain from the overall pain from the procedure. There are 6 faces ranging from 0 no hurt to 10 hurts the worst.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Signed informed consent to participate in the study.

    • Male or Female subjects, ≥ 18 and ≤ 60 years of age at the time of enrollment.

    • All Fitzpatrick Skin Types are eligible

    • General good health confirmed by medical history and skin examination of the area to be treated

    • Subjects fifth finger is 17-23mm in diameter at the distal phalanges.

    Exclusion Criteria:
    • • Subject has had a surgical procedure(s) in the intended area of treatment in the last 6 months.

    • Sensitivity to the cold or history of cold-induced diseases including Raynaud's disease and cryoglobulinemia

    • Subject has a history of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.

    • Suffering from significant skin conditions in treatment areas or inflammatory skin condition, including but not limited to open lacerations or abrasions, hidradenitis, or dermatitis of the treatment area prior to treatment (duration of resolution as per the Principal Investigator's discretion) or during the treatment course.

    • History of keloid scarring, abnormal wound healing and /or prone to bruising.

    • History of epidermal or dermal disorders (Particularly if involving collagen or micro vascularity) including collagen vascular disease or vasculitis disorders

    • Subject is unable or unwilling to comply with the study requirements.

    • Subject is currently enrolled or has been enrolled within the prior 3 months in a clinical study of any other unapproved investigational drug or device.

    • Any other condition that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 MGH Clinical Unit for Research Trials & Outcomes in Skin Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: Dieter Manstein, MD, PhD, Massachusetts General Hospital
    • Principal Investigator: Neera Nathan, MD, MSHS, Massachusetts General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dieter Manstein, MD, Principal Investigator, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT05329493
    Other Study ID Numbers:
    • 2022P000271
    First Posted:
    Apr 15, 2022
    Last Update Posted:
    Jun 3, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Dieter Manstein, MD, Principal Investigator, Massachusetts General Hospital

    Study Results

    No Results Posted as of Jun 3, 2022